Peptides
PT-141 is the only sexual health treatment that targets desire at the neurological level — not blood vessels. Here's what the clinical evidence actually shows about how it works, who it helps, and how to use it safely.
Peptides
PT-141, also known by its generic name bremelanotide, is one of the most clinically significant peptides in sexual medicine. Unlike the PDE5 inhibitors you've heard of—sildenafil (Viagra) and tadalafil (Cialis)—PT-141 works directly in the brain to generate sexual desire and arousal. It's the only
Peptides
PT-141 works in the brain to create sexual desire — not in the genitals like Viagra. Here's the complete 2026 clinical guide to bremelanotide.
Peptides
If you've been curious about peptide therapy for sexual health, PT-141 — also known by its generic name bremelanotide — has probably come up. Unlike the blue pills most people know, PT-141 doesn't work by increasing blood flow. It goes straight to the brain. That's what
Peptides
PT-141 (bremelanotide) acts on the brain's desire circuitry — not blood flow — to enhance sexual motivation in both women and men. Here's everything you need to know about this FDA-approved peptide.
Peptides
PT-141, known generically as bremelanotide, is a synthetic peptide with a unique place in sexual medicine: it's the only FDA-approved peptide therapy for sexual dysfunction, and it works in a fundamentally different way than anything that came before it. While Viagra and Cialis target blood vessels, PT-141 targets
Peptides
If you've ever looked into treatments for low libido or sexual dysfunction, you may have come across PT-141 — a peptide that works unlike anything else on the market. Unlike Viagra or Cialis, which act on blood vessels, PT-141 (bremelanotide) targets the brain directly, activating the neural circuits responsible
Peptides
Most drugs that treat sexual dysfunction work by improving blood flow. PT-141 takes a completely different approach—it works on the brain. Also known by its generic name bremelanotide, PT-141 is a melanocortin receptor agonist that activates specific neural pathways involved in sexual motivation and arousal. It's the
Peptides
PT-141, the peptide better known by its generic name bremelanotide, occupies a genuinely unique position in the pharmacology of sexual dysfunction. Unlike every other drug in this space — Viagra, Cialis, flibanserin — it does not work on the genitals. It works on the brain. Specifically, it targets a network of melanocortin
Peptides
PT-141
PT-141 (Bremelanotide): Mechanism, Efficacy, and Clinical Considerations PT-141, marketed under the brand name Bremelanotide, represents a significant advancement in pharmacological treatment for hypoactive sexual desire disorder (HSDD) in women. In June 2019, the FDA approved Bremelanotide as the first melanocortin receptor agonist indicated for premenopausal women with generalized HSDD, making